In current skin cancer therapies, NPs loaded with anticancer agents are generally administered through topical/transdermal, intratumoral (local), or systemic (intravenous) routes or through a combination of these ().Topical or transdermal applications are noninvasive and self-administered approaches considered for elderly patients, those not considered candidates for surgical treatment, and